Yael L. Maxwell's profile photo

Yael L. Maxwell

Senior Medical Journalist at TCTMD

Senior Medical Journalist @TCTMD & #FellowsForum Section Editor. Mama to 2 tiny humans. Student of the world. All tweets my own. @yaelmaxwell.bsky.social

Featured in: Favicon tctmd.com Favicon mentalfloss.com Favicon refinery29.com Favicon newsbreak.com Favicon acponline.org Favicon octnews.org Favicon ourcommunitynow.com Favicon citylifestyle.com Favicon acphospitalist.acponline.org

Articles

  • Early Coronary Function Testing Improves Quality of Life in ANOCA

    1 week ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 In the ILIAS ANOCA trial, using CFT to guide treatment according to ANOCA endotype led to larger QoL gains over 6 months.

  • Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

    2 weeks ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 As patients experience all events, not just the first, researchers should consider adjusting their trials to capture all outcomes. PARIS, France—One month of dual antiplatelet therapy (DAPT) after PCI using contemporary stents not only is associated with similar rates of adverse clinical outcomes compared with 3 months or more in patients at high bleeding risk, but also lowers the total number of events, according to new data from MASTER DAPT.

  • IVL Effective in Severely Calcified Lesions, Especially in Women

    2 weeks ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 EMPOWER-CAD and BALI reinforce the utility of coronary lithotripsy, but the effect on hard outcomes is still unclear. PARIS, France—Intravascular lithotripsy (IVL) can safely aid in lesion preparation before PCI in patients with severe calcification and can lower the rate of postprocedural patient adverse outcomes, according to data from two new studies presented here at EuroPCR 2025. In BALI, presented by Andreas T.

  • Early TAVI Improves Prognosis in Asymptomatic AS No Matter the Extent of Cardiac Damage

    2 weeks ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 Researchers say the data underscore the need for more aggressive surveillance of patients, even when AS is moderate AS. PARIS, France—Cardiac damage is present in four out of every five patients with asymptomatic aortic stenosis (AS) and is tied to worse prognosis over time, but new data from the EARLY TAVR trial suggest that TAVI improves clinical outcomes in all patients regardless of the extent of that damage.

  • Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

    2 weeks ago | tctmd.com | Yael L. Maxwell

    Current guidelines support culprit-only PCI in these cases, but the “hypothesis-generating” results suggest taking a closer look. PARIS, France—Immediate multivessel PCI offers similar survival out to 180 days when compared with culprit-only PCI among STEMI patients with cardiogenic shock, according to provocative new data from the DanGer Shock trial.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
4K
Tweets
6K
DMs Open
No
Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
8 May 25

RT @lamckeown1: "BATMAN was technically feasible, associated with short procedural times, and highly effective in enabling TMVR in patients…

Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
5 May 25

Although the genes that affect Lp(a) in European and East Asian populations might vary, the downstream clinical effects that stem from high Lp(a) levels are similar, according to data from the UK and China. https://t.co/N6PjpfCviQ

Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
1 May 25

RT @TCTMD: FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis https://t.co/Tio4vD9uH3 https://t.co/der1ZIOdgh